NCT06432959COMPLETEDNAIn this study, the investigators will test whether the incorporation of positive affect promoting activities in treatment sessions improves outcomes in the context of CBT for depression and DBT for problems of emotion dysregulation. In clinics focused on each of these treatments, the investigators will evaluate these treatments with and without the addition of positive affect promoting activities.
No linked publications found in PubMed
Clinic-specific inclusion criteria are as follows. For the clinic providing CBT for depression, participants must meet criteria for a diagnosis of major depressive disorder according to Diagnostic and Statistical Manual-5 (DSM-5). They must also be able to attend in-person sessions or have access to a reliable internet connection to participate in virtual sessions. For the clinic providing DBT, participants must evidence severe emotion dysregulation defined as (1) meeting criteria for borderline personality disorder (BPD) or (2) elevated indicators of borderline personality pathology defined as average scores of 1.5 on the Personality Inventory for DSM-5 (PID-5) Negative Affectivity scale and 1.25 on the Antagonism scale and/or 1.25 on the Disinhibition scale. They must also be willing and able to attend in-person sessions. Across both clinics, the following inclusion and exclusion criteria will be applied: Inclusion Criteria: 1. 18 years old or older 2. residence in the state of Ohio 3. able and willing to give informed consent Exclusion Criteria: 1. current or past diagnosis of bipolar disorder or a psychotic disorder 2. presence of a psychiatric disorder other than Major Depressive Disorder (MDD) or BPD, if it constitutes the predominant aspect of the clinical presentation and if it requires treatment other than that being offered (including substance use disorders involving heroin, cocaine, and methamphetamine deemed inappropriate at pre-screening) 3. currently participating in a psychosocial treatment for an emotional disorder, including any individual psychotherapy 4. if on psychiatric medication, no changes to medication regimen (drugs or dosage) in the past month and no intention to modify medication regimen for the next 12 weeks 5. clear indication of secondary gain (e.g., court-ordered treatment) 6. current suicide risk of medical instability (e.g., low weight) to preclude treatment on an outpatient basis